Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ruiqi Zhang & Ivan Fan-Ngai Hung. (2021) Approaches in broadening the neutralizing antibody response of the influenza vaccine. Expert Review of Vaccines 20:12, pages 1539-1547.
Read now
Read now
Francesco Lapi, Ettore Marconi, Monica Simonetti, Vincenzo Baldo, Alessandro Rossi, Aurelio Sessa & Claudio Cricelli. (2019) Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly. Expert Review of Vaccines 18:6, pages 663-670.
Read now
Read now
Guglielmo Dini, Alessandra Toletone, Laura Sticchi, Andrea Orsi, Nicola Luigi Bragazzi & Paolo Durando. (2018) Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature. Human Vaccines & Immunotherapeutics 14:3, pages 772-789.
Read now
Read now
Adam Kenneth Wheatley & Stephen John Kent. (2015) Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Review of Vaccines 14:9, pages 1227-1239.
Read now
Read now
Susanna Esposito & Nicola Principi. (2015) Influenza vaccination in pediatric age. Expert Review of Vaccines 14:6, pages 785-787.
Read now
Read now
Articles from other publishers (23)
Juan F. Hernandez-Franco, Ganesh Yadagiri, Veerupaxagouda Patil, Dina Bugybayeva, Sara Dolatyabi, Ekachai Dumkliang, Mithilesh Singh, Raksha Suresh, Fatema Akter, Jennifer Schrock, Gourapura J. Renukaradhya & Harm HogenEsch. (2023) Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization. Vaccines 11:11, pages 1699.
Crossref
Crossref
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines
514
551.e31
.
Juan F. Hernandez-Franco, Shaojun Xie, Jyothi Thimmapuram, Darryl Ragland & Harm HogenEsch. (2022) Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant. Frontiers in Immunology 13.
Crossref
Crossref
Pu Shan, Zhibiao Wang, Jilai Li, Duoqian Wei, Zhuan Zhang, Shaojie Hao, Yibo Hou, Yunyang Wang, Shuxiang Li, Xudong Wang & Jing Xu. (2022) A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
119
164
.
Birgit Weinberger. (2021) Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immunity & Ageing 18:1.
Crossref
Crossref
Han Zhang, Huaguo Zheng, Peng Guo, Liuyi Hu, Zihao Wang, Jiuru Wang, Ying Ju & Songdong Meng. (2021)
Broadly Protective CD8
+
T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine
. Journal of Virology 95:12.
Crossref
Crossref
Angelika Wagner & Birgit Weinberger. (2020) Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Frontiers in Immunology 11.
Crossref
Crossref
Edward A. Belongia, Min Z. Levine, Oluwatosin Olaiya, F. Liaini Gross, Jennifer P. King, Brendan Flannery & Huong Q. McLean. (2020) Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017–2018. Vaccine 38:15, pages 3121-3128.
Crossref
Crossref
Ivo Vojtek, Philippe Buchy, T. Mark Doherty & Bernard Hoet. (2019) Would immunization be the same without cross-reactivity?. Vaccine 37:4, pages 539-549.
Crossref
Crossref
Birgit Weinberger. (2018) Adjuvant strategies to improve vaccination of the elderly population. Current Opinion in Pharmacology 41, pages 34-41.
Crossref
Crossref
Joseph S. Bresee, Alicia M. Fry, Suryaprakash Sambhara & Nancy J. Cox. 2018. Plotkin's Vaccines. Plotkin's Vaccines
456
488.e21
.
Amanda L. Wilkins, Dmitri Kazmin, Giorgio Napolitani, Elizabeth A. Clutterbuck, Bali Pulendran, Claire-Anne Siegrist & Andrew J. Pollard. (2017) AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Frontiers in Immunology 8.
Crossref
Crossref
James D. Allen, Simon O. Owino, Donald M. Carter, Corey J. Crevar, Valerie A. Reese, Christopher B. Fox, Rhea N. Coler, Steven G. Reed, Susan L. Baldwin & Ted M. Ross. (2017) Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines. Vaccine 35:38, pages 5209-5216.
Crossref
Crossref
Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, Silvia Maccari, Raffaella Cecchi, Jeffrey B. Ulmer, Ennio De Gregorio, Andrew J. Geall, Michela Brazzoli & Sylvie Bertholet. (2016) Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge. PLOS ONE 11:8, pages e0161193.
Crossref
Crossref
Ivan Fan-Ngai Hung, Anna Jinxia Zhang, Kelvin Kai-Wang To, Jasper Fuk-Woo Chan, Patrick Li, Tin-Lun Wong, Ricky Zhang, Tuen-Ching Chan, Brian Chun-Yuan Chan, Harrison Ho Wai, Lok-Wun Chan, Hugo Pak-Yiu Fong, Raymond Kar-Ching Hui, Ka-Lun Kong, Arthur Chun-Fung Leung, Abe Ho-Ting Ngan, Louise Wing-Ki Tsang, Alex Pat-Chung Yeung, Geo Chi-Ngo Yiu, Wing Yung, Johnson Y-N Lau, Honglin Chen, Kwok-Hung Chan & Kwok-Yung Yuen. (2016) Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. The Lancet Infectious Diseases 16:2, pages 209-218.
Crossref
Crossref
Mark Mullikin, Litjen Tan, Jeroen P. Jansen, Marc Van Ranst, Norbert Farkas & Eckhardt Petri. (2015) A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly. Infectious Diseases and Therapy 4:4, pages 459-487.
Crossref
Crossref
Ryo Arakane, Ryosuke Annaka, Akiko Takahama, Katsuyasu Ishida, Michiharu Yoshiike, Tetsuo Nakayama & Fumihiko Takeshita. (2015) Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study. Vaccine 33:48, pages 6650-6658.
Crossref
Crossref
Claudia Pileggi, Valentina Mascaro, Aida Bianco, Carmelo G. A. Nobile & Maria Pavia. (2015) Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials. Drugs & Aging 32:10, pages 857-869.
Crossref
Crossref
Barbara Camilloni, Michela Basileo, Angela Di Martino, Isabella Donatelli & Anna Maria Iorio. (2014) Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains. Immunity & Ageing 11:1.
Crossref
Crossref
Pierre-Olivier Lang. (2013) Why Influenza Viruses Continue to Pose a Significant Threat to Aging and Aged Populations Worldwide. Current Geriatrics Reports 3:1, pages 56-65.
Crossref
Crossref
Philip R. Dormitzer. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II
237
273
.
Theodore F Tsai. (2013) Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults. Infection & Chemotherapy 45:2, pages 159.
Crossref
Crossref